Article Text

Download PDFPDF
Non-infective cystitis secondary to benralizumab immunotherapy
  1. Toby Murray1,
  2. Ben Haagsma2 and
  3. Andrew Chetwood1
  1. 1Urology, Frimley Park Hospital NHS Foundation Trust, Frimley, UK
  2. 2Histopathology, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK
  1. Correspondence to Dr Toby Murray; toby.murray{at}nhs.net

Abstract

This case study discusses a patient who presented with severe lower urinary tract symptoms and pain after commencing immunotherapy for eosinophilic asthma. Initial aetiology was presumed to be infective but cultures were negative. Cross-sectional imaging showed extensive perivesical and periprostatic stranding and inflammation. He was initially treated with antibiotics and anti-inflammatories but a lack of clinical improvement led to a rigid cystoscopy which identified an inflamed, oedematous urothelium which was biopsied. Histology demonstrated extensive, full thickness superficial detrusor inflammation, with marked congestion, oedema and a mixed inflammatory infiltrate in keeping with a severe active chronic non-infectious cystitis, possibly secondary to benralizumab therapy. His benralizumab was stopped and his symptoms completely settled. We believe this is the first described case of severe non-infective cystitis which may be secondary to benralizumab. This case adds to the isolated reports of this rare side effect of some of the newer biological agents in use.

  • immunological products and vaccines
  • urinary and genital tract disorders
  • immunology
  • unwanted effects / adverse reactions
  • respiratory system

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors AC was lead clinician for the patient, performed the investigations and led the clinical management. TM is lead author and wrote the manuscript with supervision provided by AC. BH examined the histology and provided imaging and their subsequent descriptions for the manuscripts.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.